Literature DB >> 17305546

Selectivity and affinity determinants for ligand binding to the aromatic amino acid hydroxylases.

Knut Teigen1, Jeffrey Alan McKinney, Jan Haavik, Aurora Martínez.   

Abstract

Hydroxylation of the aromatic amino acids phenylalanine, tyrosine and tryptophan is carried out by a family of non-heme iron and tetrahydrobiopterin (BH4) dependent enzymes, i.e. the aromatic amino acid hydroxylases (AAHs). The reactions catalyzed by these enzymes are important for biomedicine and their mutant forms in humans are associated with phenylketonuria (phenylalanine hydroxylase), Parkinson's disease and DOPA-responsive dystonia (tyrosine hydroxylase), and possibly neuropsychiatric and gastrointestinal disorders (tryptophan hydroxylase 1 and 2). We attempt to rationalize current knowledge about substrate and inhibitor specificity based on the three-dimensional structures of the enzymes and their complexes with substrates, cofactors and inhibitors. In addition, further insights on the selectivity and affinity determinants for ligand binding in the AAHs were obtained from molecular interaction field (MIF) analysis. We applied this computational structural approach to a rational analysis of structural differences at the active sites of the enzymes, a strategy that can help in the design of novel selective ligands for each AAH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17305546     DOI: 10.2174/092986707779941023

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  9 in total

1.  Production of tyrosine through phenylalanine hydroxylation bypasses the intrinsic feedback inhibition in Escherichia coli.

Authors:  Jin Huang; Yuheng Lin; Qipeng Yuan; Yajun Yan
Journal:  J Ind Microbiol Biotechnol       Date:  2015-02-03       Impact factor: 3.346

2.  Cloning and characterization of a novel enzyme: tyrosine hydroxylase from Schistosoma japonicum.

Authors:  Yuansheng Hu; Dujuan Shi; Qingli Luo; Qingzhong Liu; Yindi Zhou; Lili Liu; Li Yu; Wei Wei; Jilong Shen
Journal:  Parasitol Res       Date:  2011-05-10       Impact factor: 2.289

3.  Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria.

Authors:  Angel L Pey; Ming Ying; Nunilo Cremades; Adrian Velazquez-Campoy; Tanja Scherer; Beat Thöny; Javier Sancho; Aurora Martinez
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

4.  L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat.

Authors:  Zachary D Brodnik; Manda Double; Rodrigo A España; George E Jaskiw
Journal:  Neuropharmacology       Date:  2017-05-29       Impact factor: 5.250

Review 5.  Phenylalanine hydroxylase misfolding and pharmacological chaperones.

Authors:  Jarl Underhaug; Oscar Aubi; Aurora Martinez
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

6.  Structural and thermodynamic insight into phenylalanine hydroxylase from the human pathogen Legionella pneumophila.

Authors:  Hanna-Kirsti S Leiros; Marte Innselset Flydal; Aurora Martinez
Journal:  FEBS Open Bio       Date:  2013-08-19       Impact factor: 2.693

7.  Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole-In Vitro and In Vivo Investigations.

Authors:  Nibal Betari; Kristoffer Sahlholm; Xavier Morató; Héctor Godoy-Marín; Olga Jáuregui; Knut Teigen; Francisco Ciruela; Jan Haavik
Journal:  Front Pharmacol       Date:  2020-11-26       Impact factor: 5.810

8.  Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation.

Authors:  María Teresa Bueno-Carrasco; Jorge Cuéllar; Marte I Flydal; César Santiago; Trond-André Kråkenes; Rune Kleppe; José R López-Blanco; Miguel Marcilla; Knut Teigen; Sara Alvira; Pablo Chacón; Aurora Martinez; José M Valpuesta
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

9.  Dynamic regulation of phenylalanine hydroxylase by simulated redox manipulation.

Authors:  Julian E Fuchs; Roland G Huber; Susanne von Grafenstein; Hannes G Wallnoefer; Gudrun M Spitzer; Dietmar Fuchs; Klaus R Liedl
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.